NO992710L - Process for the preparation of metal complex carboxylic acid amides - Google Patents

Process for the preparation of metal complex carboxylic acid amides

Info

Publication number
NO992710L
NO992710L NO992710A NO992710A NO992710L NO 992710 L NO992710 L NO 992710L NO 992710 A NO992710 A NO 992710A NO 992710 A NO992710 A NO 992710A NO 992710 L NO992710 L NO 992710L
Authority
NO
Norway
Prior art keywords
carboxylic acid
metal complex
complex carboxylic
acid amides
preparation
Prior art date
Application number
NO992710A
Other languages
Norwegian (no)
Other versions
NO992710D0 (en
NO312724B1 (en
Inventor
Heribert Schmitt-Willich
Johannes Platzek
Klaus-Dieter Graske
Chel Bernd Rad
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO992710D0 publication Critical patent/NO992710D0/en
Publication of NO992710L publication Critical patent/NO992710L/en
Publication of NO312724B1 publication Critical patent/NO312724B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/143—Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to a method for producing metal complex carboxylic acid amides characterized in that a metal complex carboxylic acid mixture consisting of metal complex carboxylic acid and at least one solubilizing substance is pretreated in dimethylsulfoxide (DSMO) with a dehydrating reagent, optionally by adding a coupling adjuvant and made to react with a amine of general formula (I): A(NH2)n, wherein A means the radical of a natural or synthetic amine and n stands for the figures 1 to 100.
NO19992710A 1996-12-04 1999-06-03 Process for the preparation of metal complex carboxylic acid amides NO312724B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19652386A DE19652386A1 (en) 1996-12-04 1996-12-04 Process for the preparation of metal complex carboxamides
PCT/EP1997/006594 WO1998024775A1 (en) 1996-12-04 1997-11-26 Method for producing metal complex carboxylic acid amides

Publications (3)

Publication Number Publication Date
NO992710D0 NO992710D0 (en) 1999-06-03
NO992710L true NO992710L (en) 1999-06-03
NO312724B1 NO312724B1 (en) 2002-06-24

Family

ID=7814928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992710A NO312724B1 (en) 1996-12-04 1999-06-03 Process for the preparation of metal complex carboxylic acid amides

Country Status (12)

Country Link
EP (1) EP0946525B1 (en)
JP (1) JP4278182B2 (en)
AT (1) ATE263758T1 (en)
AU (1) AU5556698A (en)
DE (2) DE19652386A1 (en)
DK (1) DK0946525T3 (en)
ES (1) ES2218711T3 (en)
NO (1) NO312724B1 (en)
PT (1) PT946525E (en)
TW (1) TW438804B (en)
WO (1) WO1998024775A1 (en)
ZA (1) ZA9710930B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19905094C1 (en) * 1999-02-01 2000-10-12 Schering Ag Gadolinium (III) complexes and their use for two-step forms of radiation therapy and pharmaceutical compositions containing them
DE10105014C2 (en) * 2001-01-26 2003-03-27 Schering Ag New process for the production of DTPA monoamides
FR2856063B1 (en) * 2003-06-13 2005-10-07 Air Liquide PROCESS FOR THE PREPARATION OF CIS-8B-METHYLDECAHYDRO-2A, 4A, 6A, 8A-TETRAAZACYCLOPENTA [FG] ACENAPHTHYLENE, OR CIS-DECAHYDRO-2A, 4A, 6A, 8A-TETRAAZACYCLOPENTA [FG] ACENAPHTHYLENE, CYCLENE, AND CYCLENES FUNCTIONALISED
DE102007002726A1 (en) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft New cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
DE102007058220A1 (en) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors
KR101334780B1 (en) 2010-08-13 2013-12-02 한국생명공학연구원 Iodine-containing radial-shape macromolecular compounds, preparation method thereof and contrast medium compositions for CT comprising the same
EP2956461A1 (en) 2013-02-12 2015-12-23 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN110035996B (en) 2016-11-28 2022-08-09 拜耳医药股份公司 Novel highly relaxant gadolinium chelates for magnetic resonance imaging
KR20210095168A (en) 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 Formulation of Contrast Media and Method for Preparing Same
CN111004623B (en) * 2019-12-20 2023-07-18 河北科技大学 Porphyrin fluorescent material and preparation method thereof
EP4360660A1 (en) 2022-10-24 2024-05-01 Bayer AG Process for the preparation of a gadolinium contrast agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316757A (en) * 1984-10-18 1994-05-31 Board Of Regents, The University Of Texas System Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
DE3625417C2 (en) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecane derivatives
DE4218744C2 (en) * 1992-06-04 1997-11-06 Schering Ag Process for the preparation of N-β-hydroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and their metal complexes

Also Published As

Publication number Publication date
TW438804B (en) 2001-06-07
WO1998024775A1 (en) 1998-06-11
NO992710D0 (en) 1999-06-03
AU5556698A (en) 1998-06-29
ATE263758T1 (en) 2004-04-15
NO312724B1 (en) 2002-06-24
EP0946525B1 (en) 2004-04-07
DE19652386A1 (en) 1998-06-10
PT946525E (en) 2004-08-31
DE59711504D1 (en) 2004-05-13
JP2001504844A (en) 2001-04-10
DK0946525T3 (en) 2004-08-02
ES2218711T3 (en) 2004-11-16
EP0946525A1 (en) 1999-10-06
JP4278182B2 (en) 2009-06-10
ZA9710930B (en) 1998-09-08

Similar Documents

Publication Publication Date Title
NO992710L (en) Process for the preparation of metal complex carboxylic acid amides
DE69433010D1 (en) METHOD FOR PRESENTING OLIGONUCLEOTIDES
ATE136899T1 (en) METHOD FOR PRODUCING AN N-PHENYLACETYL DERIVATIVE OF TETRAHYDROTHIENO(3,2- C>PYRIDINE AND SYNTHESIS INTERMEDIATE
ATE317912T1 (en) METHOD FOR PRODUCING BETA-LACTAMEN
RU92016568A (en) METHOD OF OBTAINING BETA LACTAM DERIVATIVES
ATE144493T1 (en) METHOD AND PRODUCTION OF SALICYL LDOXIM DERIVATIVES
PL319692A1 (en) Method of obtaining substituted 3-amino benzonitriles
EP0882767A4 (en) Bisazo compounds and process for the preparation thereof
NZ514653A (en) Process for producing an amide compound by reacting a compound with an amino group with a polyaminocarboxylic acid anhydride
DE3375569D1 (en) Improvement in the process for preparing biaryl compounds via coupling of an arylamine with an arene
UA8032A1 (en) METHOD FOR SYNTHESIZING 2-(4-METOXYPHENYLPROPIONYL)AMINO-6-n-PROPYLAMINO-4,5,6,7-TETRAHYDROBENZOTHIASOL IN FORM OF RACEMATE OR (-)-ENANTIOMER OR ITS ACID ADDITIVE SALT
DK0700294T3 (en) Injection solution for intramuscular and subcutaneous administration in animals
BR9605027A (en) Process for preparing a b-trifluor-methyl & b-unsaturated carboxylate
HK1027560A1 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
KR920016441A (en) Glyceraldehyde-3-pentanide and preparation method thereof
ATE159519T1 (en) METHOD FOR PRODUCING N-PHENYL-N-(4-PIPERIDINYL)AMIDE DERIVATIVES
IL141010A (en) Method for producing atropic acid ethyl ester
ATE366255T1 (en) METHOD FOR PRODUCING HALOGENATED BETA-LACTAM COMPOUNDS
EP0106282A3 (en) Production of caerulein intermediate
BG101525A (en) Method for the preparation of aromatic o-sulphocarboxylic aicds and sulphonylcarbamides
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
DE69938661D1 (en) METHOD FOR PRODUCING AN INDOINDIVATE
YU78793A (en) N-CYCLOALKYL AMIDES OF PRIVALIC ACID AND THE PROCEDURE FOR OBTAINING THEM
IL105657A (en) Process for the preparation of 5-chloroxindole
RU93011399A (en) METHOD FOR PRODUCING WATER BINDING DISPERSED ALUMINOSILICATE SYSTEMS

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees